Citadel Advisors’s InfuSystem Holdings INFU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57M Buy
169,954
+100,238
+144% +$875K ﹤0.01% 6619
2025
Q4
$625K Sell
69,716
-98,987
-59% -$947K ﹤0.01% 8482
2025
Q3
$1.75M Sell
168,703
-181,859
-52% -$1.51M ﹤0.01% 6351
2025
Q2
$2.19M Buy
350,562
+174,991
+100% +$967K ﹤0.01% 5538
2025
Q1
$945K Buy
175,571
+112,781
+180% +$825K ﹤0.01% 7079
2024
Q4
$531K Sell
62,790
-19,804
-24% -$156K ﹤0.01% 8423
2024
Q3
$553K Buy
82,594
+30,009
+57% +$194K ﹤0.01% 8045
2024
Q2
$359K Buy
52,585
+36,824
+234% +$271K ﹤0.01% 8760
2024
Q1
$135K Buy
15,761
+12,308
+356% +$116K ﹤0.01% 10924
2023
Q4
$36.4K Sell
3,453
-13,818
-80% -$136K ﹤0.01% 12096
2023
Q3
$166K Buy
17,271
+15,031
+671% +$154K ﹤0.01% 10193
2023
Q2
$21.6K Sell
2,240
-25,692
-92% -$233K ﹤0.01% 12672
2023
Q1
$216K Buy
27,932
+16,431
+143% +$151K ﹤0.01% 10043
2022
Q4
$99.8K Buy
+11,501
New +$93.7K ﹤0.01% 11220
2022
Q3
Sell
-35,296
Closed -$340K 13082
2022
Q2
$340K Buy
35,296
+5,765
+20% +$50.5K ﹤0.01% 9526
2022
Q1
$289K Sell
29,531
-1,982
-6% -$25.5K ﹤0.01% 10677
2021
Q4
$537K Sell
31,513
-645
-2% -$10.2K ﹤0.01% 9525
2021
Q3
$419K Buy
32,158
+2,967
+10% +$48.4K ﹤0.01% 10302
2021
Q2
$607K Buy
+29,191
New +$590K ﹤0.01% 9588
2021
Q1
Sell
-50,883
Closed -$955K 13444
2020
Q4
$955K Buy
50,883
+2,912
+6% +$43.9K ﹤0.01% 6890
2020
Q3
$615K Buy
47,971
+35,453
+283% +$461K ﹤0.01% 6918
2020
Q2
$144K Buy
+12,518
New +$144K ﹤0.01% 8772
2018
Q1
Sell
-10,946
Closed -$25K 8513
2017
Q4
$25K Buy
+10,946
New +$23.7K ﹤0.01% 7797
2017
Q3
Sell
-10,711
Closed -$19K 7750
2017
Q2
$19K Buy
+10,711
New +$19.3K ﹤0.01% 7302
2014
Q2
Sell
-19,266
Closed -$54K 8107
2014
Q1
$54K Buy
+19,266
New +$49.6K ﹤0.01% 6717
2013
Q4
Sell
-14,053
Closed -$18K 7080
2013
Q3
$18K Buy
+14,053
New +$20.7K ﹤0.01% 6263

Other funds holding INFU

Citadel Advisors's INFU Position: Q1 2026 in Review

Citadel Advisors increased its InfuSystem Holdings (INFU) stake by 144% in Q1 2026, buying an estimated $875K and bringing the position to 169,954 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #6619.

Citadel Advisors first reported a position in INFU in Q3 2013 and has held it in 26 quarters since. The position peaked at $2.19M in Q2 2025. 96 funds tracked by Wall St. Rank hold INFU as of Q1 2026.

  • Citadel Advisors held 169,954 shares of InfuSystem Holdings worth $1.57M as of Q1 2026.
  • Citadel Advisors bought 100,238 InfuSystem Holdings shares in Q1 2026, an estimated $875K.
  • InfuSystem Holdings made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6619 holding.
  • Citadel Advisors first reported a position in InfuSystem Holdings in Q3 2013 and has held it in 26 quarters since.
  • Citadel Advisors's InfuSystem Holdings position peaked at $2.19M in Q2 2025.
  • 96 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.